Culture yield of Neisseria gonorrhoeae: culture yield varies by anatomical site and time to culture collection
Sexual Health · 2026
DOI: 10.1071/sh25242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sexual Health, 2026. Verfasst von Jun Jung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Melbourne Sexual Health Centre, Bayside Health, Melbourne, Vic, Australia. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Gonorrhea, Specimen Handling. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Neisseria gonorrhoeae (NG) is one of the World Health Organization’s high-priority bacterial pathogens due to the emergence of multidrug-resistant strains. The culture of NG remains important for providing antimicrobial resistance surveillance data.
Objective
To determine the NG culture yield following a positive NG nucleic acid amplification test (NAAT) within 30 days, stratified by culture specimen collection sites, the time interval between NAAT and culture, and gender.
Methods
A retrospective data analysis of positive NG NAAT specimens of individuals attending the Melbourne Sexual Health Centre between April 2015 and March 2023. We calculated the NG culture yield within 30 days and stratified by culture specimen collection sites.
Results
The NG culture yield was lowest in the pharynx (37.9%, 95% confidence interval (CI) 36.6–39.2, 1964/5185) followed by the vagina (41.6%, 95% CI 37.0–46.3, 186/447), cervix (60.1%, 95% CI 52.2–67.7, 98/163), rectum (68.0%, 95% CI 66.6–69.3, 3223/4742) and urethra (97.0%, 95% CI 96.4–97.6, 3282/3382). The overall NG culture yield was 77.8% (95% CI 76.8–78.8, 5254/6754) when the culture was performed on the same date as the NAAT test, and it decreased significantly to 53.6% (95% CI 51.5–55.7, 1193/2224) 1–3 days after the NAAT-positive specimens were collected, then to 37.1% (95% CI 30.7–43.7, 83/224) 15–30 days after the NAAT-positive specimens were collected (Ptrend <0.001).
Conclusions
The culture specimen collection sites and time to culture collection influenced the culture yield. NG culture should be performed as close as possible to NAAT testing to improve NG culture yield. In addition, combining molecular resistance testing with culture-based techniques may be necessary to ensure adequate antimicrobial resistance detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Melbourne Sexual Health Centre, Bayside Health, Melbourne, Vic, Australia.
- Department of General Practice and Primary Care, Melbourne Medical School, The University of Melbourne, Parkville, Vic, Australia.
- Centre for Digital Transformation of Health, The University of Melbourne, Carlton, Vic, Australia.
- School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic, Australia.
- Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Vic, Australia.
- Department of Infectious Diseases, Austin Health, Heidelberg, Vic, Australia.
ORCID-Profile: Jun Jung, Eric P F Chow
Zitieren
APA
Jung, J., Chen, M. Y., Sherry, N. L., De Petra, V., Fairley, C. K., & Chow, E. P. F. (2026). Culture yield of Neisseria gonorrhoeae: culture yield varies by anatomical site and time to culture collection. Sexual Health. https://doi.org/10.1071/sh25242
Vancouver
Jung J, Chen MY, Sherry NL, De Petra V, Fairley CK, Chow EPF. Culture yield of Neisseria gonorrhoeae: culture yield varies by anatomical site and time to culture collection. Sexual Health. 2026. doi:10.1071/sh25242
BibTeX
@article{Jung2026,
author = {Jung, Jun and Chen, Marcus Y and Sherry, Norelle L and De Petra, Vesna and Fairley, Christopher K and Chow, Eric P F},
title = {Culture yield of Neisseria gonorrhoeae: culture yield varies by anatomical site and time to culture collection},
journal = {Sexual Health},
year = {2026},
doi = {10.1071/sh25242}
}
EUVIMED